Detail akcie Boston Scient online

Business Summary: Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Boston Scientific Corp revenues increased 21% to $4.66B. Net income applicable to common stockholders increased 36% to $674M. Revenues reflect Cardiovascular segment increase of 26% to $3.09B, MedSurg segment increase of 12% to $1.58B, United States segment increase of 31% to $2.96B, Asia Pacific segment increase of 8% to $701M.